Scienture Holdings, Inc. (SCNX)
NASDAQ: SCNX · Real-Time Price · USD
0.9293
-0.0404 (-4.17%)
At close: Sep 4, 2025, 4:00 PM
0.9800
+0.0507 (5.46%)
Pre-market: Sep 5, 2025, 8:00 AM EDT
Scienture Holdings Employees
As of December 31, 2024, Scienture Holdings had 19 total employees, including 14 full-time and 5 part-time employees. The number of employees did not change compared to the previous year.
Employees
19
Change (1Y)
n/a
Growth (1Y)
n/a
Revenue / Employee
$6,747
Profits / Employee
-$1,059,521
Market Cap
17.99M
Employees Chart
Employees History
Date | Employees | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 19 | 0 | - |
Dec 31, 2023 | 19 | - | - |
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 400,000 |
Johnson & Johnson | 138,100 |
Thermo Fisher Scientific | 125,000 |
Abbott Laboratories | 114,000 |
AstraZeneca | 92,900 |
Novo Nordisk | 77,349 |
Novartis AG | 75,883 |
Merck & Co. | 75,000 |
SCNX News
- 21 days ago - Scienture Holdings, Inc. Announces Pricing of $3.9 Million Registered Direct Offering of Common Stock - GlobeNewsWire
- 23 days ago - SCIENTURE announces the shipment of launch quantities of Arbli™ (losartan potassium Oral Suspension) to its 3PL/Distribution Center and receipt of first wholesaler order, marking major commercialization milestones. - GlobeNewsWire
- 6 weeks ago - Scienture Holdings, Inc. Obtains $1.2 Million in Bridge Funding - GlobeNewsWire
- 7 weeks ago - Scienture Holdings, Inc. Regains Compliance with Nasdaq Listing Requirements - GlobeNewsWire
- 2 months ago - Scienture Holdings Announces Cancelation of ELOC - GlobeNewsWire
- 3 months ago - Wellgistics Health Strengthens Executive Team and Board with Strategic Appointments to Accelerate Scale and Drive Shareholder Value - Accesswire
- 3 months ago - SCIENTURE Announces Executive Leadership Transition - GlobeNewsWire
- 3 months ago - SCIENTURE announces FDA Orange Book Patent Listing for ArbliTM, (losartanpotassium) Oral Suspension, 10mg/mL. - GlobeNewsWire